FR2130659A1 - - Google Patents

Info

Publication number
FR2130659A1
FR2130659A1 FR7210390A FR7210390A FR2130659A1 FR 2130659 A1 FR2130659 A1 FR 2130659A1 FR 7210390 A FR7210390 A FR 7210390A FR 7210390 A FR7210390 A FR 7210390A FR 2130659 A1 FR2130659 A1 FR 2130659A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7210390A
Other languages
French (fr)
Other versions
FR2130659B1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of FR2130659A1 publication Critical patent/FR2130659A1/fr
Application granted granted Critical
Publication of FR2130659B1 publication Critical patent/FR2130659B1/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/02Preparation by ring-closure or hydrogenation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/42Oxygen atoms attached in position 3 or 5

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7210390A 1971-03-25 1972-03-24 Expired FR2130659B1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19712114420 DE2114420A1 (de) 1971-03-25 1971-03-25 Substituierte Phenylalkanol-Derivate und Verfahren zu ihrer Herstellung

Publications (2)

Publication Number Publication Date
FR2130659A1 true FR2130659A1 (es) 1972-11-03
FR2130659B1 FR2130659B1 (es) 1975-03-14

Family

ID=5802691

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7210390A Expired FR2130659B1 (es) 1971-03-25 1972-03-24

Country Status (19)

Country Link
US (1) US3770748A (es)
AT (1) AT344169B (es)
AU (1) AU465561B2 (es)
BE (1) BE781212A (es)
BR (1) BR7201760D0 (es)
CA (1) CA980353A (es)
CH (2) CH588460A5 (es)
CS (4) CS163798B2 (es)
DD (1) DD96946A5 (es)
DE (1) DE2114420A1 (es)
DK (1) DK137273C (es)
ES (1) ES401198A1 (es)
FR (1) FR2130659B1 (es)
GB (1) GB1359600A (es)
IL (1) IL38972A (es)
NL (1) NL7203986A (es)
PL (1) PL83328B1 (es)
SE (1) SE374918B (es)
ZA (1) ZA721653B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3993763A (en) * 1969-03-18 1976-11-23 Ciba-Geigy Corporation Tertiary aminoacids as anti-inflammatory agents
US3936467A (en) * 1968-03-27 1976-02-03 Ciba-Geigy Corporation Hydroxyalkylenimino-phenyl-acetic acids
US4216326A (en) * 1975-01-20 1980-08-05 Sterling Drug Inc. Intermediates for preparing anti-inflammatory phenyl-lower-alkylamines
US4417052A (en) * 1980-02-15 1983-11-22 Sterling Drug Inc. Phenyl-lower-alkyl piperidines and pyrrolidines
US7064211B2 (en) * 2002-03-22 2006-06-20 Eisai Co., Ltd. Hemiasterlin derivatives and uses thereof
TWI350168B (en) * 2004-05-07 2011-10-11 Incyte Corp Amido compounds and their use as pharmaceuticals
WO2006002349A1 (en) * 2004-06-24 2006-01-05 Incyte Corporation Amido compounds and their use as pharmaceuticals
CA2584502A1 (en) * 2004-06-24 2006-01-05 Incyte Corporation 2-methylpropanamides and their use as pharmaceuticals
EP1773773A4 (en) * 2004-06-24 2009-07-29 Incyte Corp AMID COMPOUNDS AND THEIR USE AS MEDICAMENTS
NZ551603A (en) 2004-06-24 2010-11-26 Incyte Corp N-substituted piperidines and their use as pharmaceuticals
US20060122197A1 (en) * 2004-08-10 2006-06-08 Wenqing Yao Amido compounds and their use as pharmaceuticals
TW200808807A (en) * 2006-03-02 2008-02-16 Incyte Corp Modulators of 11-β hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same
WO2007103719A2 (en) * 2006-03-03 2007-09-13 Incyte Corporation MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
US20070293529A1 (en) * 2006-05-01 2007-12-20 Yun-Long Li Tetrasubstituted ureas as modulators of 11-beta hydroxyl steroid dehydrogenase type 1
US7838544B2 (en) * 2006-05-17 2010-11-23 Incyte Corporation Heterocyclic inhibitors of 11-β hydroxyl steroid dehydrogenase type 1 and methods of using the same

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2007554A1 (es) * 1968-04-29 1970-01-09 Geigy Ag J R
FR2085723A1 (es) * 1970-03-20 1971-12-31 Merck Patent Gmbh

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2007554A1 (es) * 1968-04-29 1970-01-09 Geigy Ag J R
FR2085723A1 (es) * 1970-03-20 1971-12-31 Merck Patent Gmbh

Also Published As

Publication number Publication date
NL7203986A (es) 1972-09-27
CA980353A (en) 1975-12-23
CS163798B2 (es) 1975-11-07
CS163797B2 (es) 1975-11-07
AU4040472A (en) 1973-09-27
ES401198A1 (es) 1975-10-01
CH605739A5 (es) 1978-10-13
ZA721653B (en) 1972-12-27
PL83328B1 (es) 1975-12-31
CH588460A5 (es) 1977-06-15
AT344169B (de) 1978-07-10
DD96946A5 (es) 1973-04-12
IL38972A0 (en) 1972-05-30
DE2114420A1 (de) 1972-10-05
AU465561B2 (en) 1973-09-27
ATA252572A (de) 1977-11-15
FR2130659B1 (es) 1975-03-14
CS168694B2 (es) 1976-06-29
US3770748A (en) 1973-11-06
BE781212A (fr) 1972-09-25
DK137273C (da) 1978-07-17
CS163796B2 (es) 1975-11-07
IL38972A (en) 1976-01-30
SE374918B (es) 1975-03-24
DK137273B (da) 1978-02-13
BR7201760D0 (pt) 1974-01-08
GB1359600A (en) 1974-07-10

Similar Documents

Publication Publication Date Title
ATA136472A (es)
AU2658571A (es)
AU2691671A (es)
AU2894671A (es)
AU3005371A (es)
AU2952271A (es)
AU2941471A (es)
AU2485671A (es)
AU2564071A (es)
AU2684071A (es)
AU2742671A (es)
AU2724971A (es)
AU2684171A (es)
AU2927871A (es)
AU2885171A (es)
AU2880771A (es)
AU2875571A (es)
AU2854371A (es)
AU2837671A (es)
AU2836771A (es)
AU2755871A (es)
AU2930871A (es)
AU2740271A (es)
AU2726271A (es)
AU2938071A (es)

Legal Events

Date Code Title Description
ST Notification of lapse